IMMX
Immix Biopharma, Inc.
Latest Form 4:Purchase$5KbyMorris Gabriel S (CFO) · filed Dec 10, 2025
Immix Biopharma, Inc. (IMMX) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 29, 2026.
- Industry:Biotechnology
- CEO:Ilya Rachman
- Employees:21
- HQ:Los Angeles, CA, US
- IPO:2021-12-16
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CFO | Purchase | 770 | $5K | Dec 10 | SEC ↗ | |
| CEO and Chairman | Purchase | 746 | $5K | Dec 10 | SEC ↗ | |
Rachman Ilya MFirst filing | CEO and Chairman | Purchase | 2,500 | $5K | Sep 17 | SEC ↗ |
Morris Gabriel SFirst filing | CFO | Purchase | 2,600 | $5K | Sep 17 | SEC ↗ |
Related companies
Immix Biopharma, Inc. is in the Healthcare sector.